SYS-CON MEDIA Authors: Gilad Parann-Nissany, Michael Bushong, Eric Brown, Kevin Benedict, PR.com Newswire

News Feed Item

Mice Model Market - by Type, Technology, Disease, Service & Care Products - Forecasts to 2018

DUBLIN, April 18, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/ddkpws/mice_model_market) has announced the addition of the "Mice Model Market - by Type, Technology, Disease, Service & Care Products - Forecasts to 2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Over the years, the use of mice models has increased rapidly. Mice have become the animals of choice for preclinical research in academic institutions as well as in pharmaceutical and biotechnology industries. The market has seen many innovations in the last few years, as companies have introduced new models for studying diseases like cancer and AIDS. The global market (models and services) is valued at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018.

This report categorizes the market into two broad segments, namely, mice models and services. By type, the market comprises of inbred, outbred, knockout, conditioned/surgically modified, hybrid/congenic, and spontaneous mutant mice. The inbred mice segment holds the largest share of 58% of the mice model market in 2013. This high share of inbred mice is attributed to their ability to reproduce the same results in different laboratories over a period of time.

The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). The breeding services market holds the largest share of the services market and is expected to grow at the highest CAGR of 15% from 2013 to 2018, to reach $521 million by 2018. The mice care products market is categorized into cages, bedding, feed, and others. The caging market accounts for the largest share of the mice care products market, growing at a CAGR of 2.8% from 2013 to 2018 to reach $67.1 million in 2018.

High investments and grants, which are leading to rising innovations in mice models, is a key factor that is likely to drive the growth of this market. In addition, the increase in the number of R&D activities in pharmaceutical industries, which are the prime users of mice models, is also responsible for driving this market. Furthermore, the high genetic similarity between mice and humans is another factor that is driving the use of mice models, globally.

Key Topics Covered:

1 Introduction
2 Executive Summary
3 Market Dynamics
4 Market Share Analysis, By Key Players
5 Mice Model Market Size
6 Geographic Analysis
7 Competitive Landscape
8 Company Profiles
9 Preclinical Pipeline
10 Industry Speaks
11 Cost Assessment and Mouse Model Outlicensing/Buyer Companies Assessment (Page No. - 230)

Companies Mentioned:

  • Ablexis, LLC
  • Charles River Laboratories, Inc.
  • Covance, Inc.
  • Crescendo Biologics,
  • Deltagen, Inc.
  • Genoway Sa
  • Harbour Antibodies Bv
  • Harlan Laboratories, Inc.
  • Immunogenes Ag
  • Ingenious Targeting Laboratory
  • Lexicon Pharmaceuticals, Inc.
  • Mirimus, Inc.
  • Sage Labs
  • Taconic Farms, Inc.
  • The Jackson Laboratory
  • Transgenic, Inc.

For more information visit http://www.researchandmarkets.com/research/ddkpws/mice_model_market

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.